Discover 27 paid clinical trials in Grand Forks, North Dakota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 27
Active & Responsive
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
for
Lung Cancer Diagnosis
Location: 36 recruiting locations
Sponsor: Freenome Holdings Inc.
Sex: All
Age: 50+
Code: NCT06122077
Recruiting
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
for
Amblyopia
Location: 59 recruiting locations
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 4 - 7
Code: NCT06380517
Phase3, Recruiting
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
for
Breast Cancer
Location: 325 recruiting locations
Sponsor: Canadian Cancer Trials Group
Sex: Female
Age: 35+
Code: NCT03488693
Phase3, Recruiting
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
for
Prostate Adenocarcinoma
Location: 417 recruiting locations
Sponsor: NRG Oncology
Sex: Male
Age: 18+
Code: NCT05050084
Phase3, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: 268 recruiting locations
Sponsor: NRG Oncology
Sex: Male
Age: 18+
Code: NCT05946213
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer
for
Extensive Stage Lung Small Cell Carcinoma,
Location: 297 recruiting locations
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04155034
Phase3, Recruiting
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
for
Locally Advanced Lung Non-Small Cell Carcinoma,
Location: 339 recruiting locations
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT05624996
Phase3, Recruiting
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial
for
Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8,
Location: 247 recruiting locations
Sponsor: NRG Oncology
Sex: Male
Age: 18+
Code: NCT04134260
Phase3, Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
for
Triple-Negative Breast Cancer
Location: 70 recruiting locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06393374
Phase3, Recruiting
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer